The Chemours Company CC
$14.58
-$0.45-2.99%
NYSE
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 15.21% | 3.83% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 15.21% | 3.83% | |||
| Cost of Revenue | 11.63% | -0.17% | |||
| Gross Profit | 34.91% | 33.33% | |||
| SG&A Expenses | 66.21% | 38.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 17.39% | 2.84% | |||
| Operating Income | -56.10% | 51.85% | |||
| Income Before Tax | 95.45% | 67.16% | |||
| Income Tax Expenses | 3,800.00% | 240.00% | |||
| Earnings from Continuing Operations | -844.83% | 53.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -844.83% | 52.46% | |||
| EBIT | -56.10% | 51.85% | |||
| EBITDA | -18.33% | -8.40% | |||
| EPS Basic | -842.23% | 52.57% | |||
| Normalized Basic EPS | -- | 100.00% | |||
| EPS Diluted | -842.23% | 53.15% | |||
| Normalized Diluted EPS | -- | 100.00% | |||
| Average Basic Shares Outstanding | 0.30% | 0.20% | |||
| Average Diluted Shares Outstanding | 0.30% | 0.20% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.89% | -0.82% | |||